Splenic vein thrombosis (SVT) is a blood clot that forms in the splenic vein — the vessel that drains blood from the spleen into the portal venous system. In roughly 50–70% of cases, the underlying cause is pancreatic disease, most commonly acute or chronic pancreatitis. The clot blocks normal venous outflow, forcing blood to reroute through collateral vessels, which can engorge the gastric veins and create gastric varices — dilated veins in the stomach wall that carry a real risk of life-threatening hemorrhage.
If you’re here because you or someone you know has been diagnosed with SVT, the most important thing to understand is this: isolated splenic vein thrombosis is not the same as portal vein thrombosis. It behaves differently, carries different risks, and often requires a different treatment approach. Many patients with SVT remain asymptomatic for months or years, but when complications arise — especially gastrointestinal bleeding — they can be severe. Let’s break down exactly what causes this condition, how it’s diagnosed, and what treatment looks like in 2024.
What Causes Splenic Vein Thrombosis?
The splenic vein runs along the posterior surface of the pancreas, which makes it uniquely vulnerable to anything happening in or around that organ. The classic teaching involves Virchow’s triad — endothelial injury, blood stasis, and hypercoagulability — and in SVT, all three mechanisms can be at play simultaneously.
Most Common Causes
| Cause | Estimated Frequency | Mechanism |
|---|---|---|
| Acute/Chronic Pancreatitis | 50–70% of cases | Direct inflammatory injury to the adjacent splenic vein wall |
| Pancreatic Cancer or Pseudocyst | 10–20% | Extrinsic compression and/or tumor invasion of the vein |
| Abdominal Surgery or Trauma | 5–10% | Mechanical injury to the vein during surgery or blunt trauma |
| Hypercoagulable States (Factor V Leiden, antiphospholipid syndrome, etc.) | 5–10% | Systemic tendency toward clot formation |
| Other (lymphoma, retroperitoneal fibrosis, liver cirrhosis) | 5–10% | Variable — compression, infiltration, or stasis |
A 2020 retrospective study in the Journal of Clinical Gastroenterology found that among 299 patients with isolated SVT, pancreatitis accounted for 60% of cases, while pancreatic malignancy was responsible for 15%. The remaining quarter had mixed or idiopathic causes.
How SVT Leads to Gastric Varices (and Why That Matters)
When the splenic vein is blocked, blood from the spleen can’t flow normally into the portal vein. Instead, it detours through the short gastric veins and gastroepiploic veins, which feed into the gastric venous plexus. These collateral veins aren’t designed to handle that volume of blood, so they dilate — forming isolated gastric varices.
This pattern is called left-sided (or sinistral) portal hypertension. It’s distinct from the generalized portal hypertension seen in cirrhosis because the liver and the rest of the portal system are typically normal. Gastric varices from SVT bleed in approximately 12–17% of cases, and when they do, the bleeding can be massive.
Splenomegaly (an enlarged spleen) develops in about 50–70% of SVT patients because the backed-up blood engorges the splenic parenchyma. This can also cause hypersplenism — low platelet counts, low white cell counts, or anemia from the overactive spleen trapping and destroying blood cells.
Diagnosis: What Tests Are Needed?
SVT is frequently discovered incidentally on imaging ordered for something else — often a CT scan for abdominal pain or follow-up of pancreatitis. Here’s what the diagnostic workup typically involves:
Imaging Studies
- Contrast-enhanced CT scan (CT angiography): The gold standard. It directly visualizes the clot as a filling defect in the splenic vein, shows collateral vessel formation, and simultaneously evaluates the pancreas for underlying pathology. Sensitivity exceeds 90%.
- Doppler ultrasound: Noninvasive and useful as a first-line screening tool. It can detect absent flow in the splenic vein and identify splenomegaly, though it’s operator-dependent and can miss smaller thrombi.
- MR venography: Helpful when CT contrast is contraindicated (e.g., contrast allergy, renal insufficiency). Provides excellent soft tissue detail and can characterize pancreatic masses simultaneously.
- Upper endoscopy (EGD): Doesn’t diagnose the clot itself, but is critical for identifying gastric varices, assessing bleeding risk, and ruling out esophageal varices.
Laboratory Tests
- Complete blood count (CBC): May reveal thrombocytopenia or pancytopenia from hypersplenism
- Coagulation panel: PT, aPTT, fibrinogen, D-dimer — helps identify underlying hypercoagulable states
- Thrombophilia workup: Factor V Leiden, prothrombin gene mutation, antiphospholipid antibodies, protein C/S levels — especially in younger patients or those without an obvious pancreatic cause
- Lipase/amylase and pancreatic tumor markers (CA 19-9): To evaluate for active pancreatitis or malignancy
Treatment: How Is Splenic Vein Thrombosis Managed?
Treatment depends entirely on whether the patient is symptomatic — specifically, whether gastric varices are present and whether they’ve bled.
Asymptomatic SVT (No Varices, No Bleeding)
Many clinicians adopt a watch-and-wait approach. If the SVT was found incidentally and the patient has no varices on endoscopy, the risk of significant complications is low. Anticoagulation may be considered in the acute phase (especially with extensive thrombosis or a known hypercoagulable state), but long-term anticoagulation for isolated, asymptomatic SVT remains controversial.
SVT with Gastric Varices but No Bleeding
This is a gray zone. Some centers recommend surveillance endoscopy every 6–12 months. Prophylactic splenectomy is occasionally discussed, but most experts reserve surgery for patients with active symptoms or high-risk variceal features.
SVT with Variceal Bleeding
Splenectomy has traditionally been the definitive treatment and remains highly effective — it eliminates the source of increased venous pressure by removing the organ whose outflow is blocked. In experienced centers, laparoscopic splenectomy is preferred when feasible.
For patients who are poor surgical candidates, alternatives include:
- Splenic artery embolization: Reduces blood flow to the spleen, lowering pressure in the collateral vessels
- Endoscopic treatment: Cyanoacrylate glue injection into bleeding gastric varices can control acute hemorrhage
- Anticoagulation therapy: Used selectively, particularly when there’s acute thrombosis extension or a documented hypercoagulable condition
Treating the Underlying Cause
This is just as important as managing the SVT itself. If pancreatitis is the driver, controlling inflammation — whether through alcohol cessation, gallstone management, or treatment of hypertriglyceridemia — can prevent clot progression. If a pancreatic tumor is compressing the vein, oncologic treatment takes priority.
When to See a Doctor
Seek medical attention promptly if you experience any of the following, particularly if you have a history of pancreatitis or pancreatic disease:
- Vomiting blood or passing black, tarry stools (signs of GI bleeding)
- Persistent or worsening left upper quadrant abdominal pain
- Unexplained anemia, low platelet count, or easy bruising
- A feeling of fullness or a palpable mass in the left upper abdomen (splenomegaly)
Frequently Asked Questions
Can splenic vein thrombosis resolve on its own?
Yes, in some cases — particularly when the underlying cause (such as acute pancreatitis) resolves. Studies have shown spontaneous recanalization of the splenic vein in up to 30–40% of patients with pancreatitis-associated SVT once inflammation subsides. However, this isn’t guaranteed, and monitoring with imaging is essential.
Is splenic vein thrombosis the same as portal vein thrombosis?
No. SVT is confined to the splenic vein and causes left-sided portal hypertension with isolated gastric varices. Portal vein thrombosis affects the main portal vein and causes more widespread portal hypertension, often with esophageal varices, ascites, and liver dysfunction. The distinction matters because management differs significantly.
Does everyone with SVT need a splenectomy?
Absolutely not. Splenectomy is generally reserved for patients who develop symptomatic gastric varices — particularly those who’ve had variceal bleeding. Many patients with asymptomatic SVT are managed conservatively with surveillance alone.
What is the ICD-10 code for splenic vein thrombosis?
The ICD-10 code is I82.890 (acute embolism and thrombosis of other specified veins). Some coders may also use I81 (portal vein thrombosis) depending on institutional practice, though I82.890 is more specific to the splenic vein.
Can you live a normal life after being diagnosed with SVT?
Most patients do, especially when the condition is caught early and the underlying cause is treated. Those who undergo splenectomy for variceal bleeding generally have excellent long-term outcomes, though they’ll need post-splenectomy vaccinations (pneumococcal, meningococcal, and Haemophilus influenzae type B) and should be aware of their increased susceptibility to encapsulated bacterial infections.
